• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Combined and independent action of proteins SP-B and SP-C in the surface behavior and mechanical stability of pulmonary surfactant films.SP-B 和 SP-C 蛋白在肺表面活性物质膜表面行为和机械稳定性中的联合和独立作用。
Biophys J. 2010 Nov 17;99(10):3290-9. doi: 10.1016/j.bpj.2010.09.039.
2
Palmitoylation of pulmonary surfactant protein SP-C is critical for its functional cooperation with SP-B to sustain compression/expansion dynamics in cholesterol-containing surfactant films.棕榈酰化肺表面活性蛋白 SP-C 对于其与 SP-B 的功能合作至关重要,以维持含有胆固醇的表面活性剂膜的压缩/扩张动力学。
Biophys J. 2010 Nov 17;99(10):3234-43. doi: 10.1016/j.bpj.2010.08.070.
3
Protein-lipid interactions and surface activity in the pulmonary surfactant system.肺表面活性物质系统中的蛋白质-脂质相互作用及表面活性
Chem Phys Lipids. 2006 Jun;141(1-2):105-18. doi: 10.1016/j.chemphyslip.2006.02.017. Epub 2006 Mar 20.
4
Segregated ordered lipid phases and protein-promoted membrane cohesivity are required for pulmonary surfactant films to stabilize and protect the respiratory surface.肺表面活性剂薄膜需要分隔有序的脂质相和蛋白促进的膜内聚性来稳定和保护呼吸表面。
Faraday Discuss. 2013;161:535-48; discussion 563-89. doi: 10.1039/c2fd20096a.
5
Surface properties of sulfur- and ether-linked phosphonolipids with and without purified hydrophobic lung surfactant proteins.含和不含纯化疏水肺表面活性蛋白的硫醚连接磷脂的表面性质
Chem Phys Lipids. 2005 Oct;137(1-2):77-93. doi: 10.1016/j.chemphyslip.2005.07.002.
6
Effects of cholesterol on surface activity and surface topography of spread surfactant films.胆固醇对铺展表面活性剂膜的表面活性和表面形貌的影响。
Biochemistry. 2002 Dec 17;41(50):15007-16. doi: 10.1021/bi0256532.
7
A combined action of pulmonary surfactant proteins SP-B and SP-C modulates permeability and dynamics of phospholipid membranes.肺表面活性剂蛋白 SP-B 和 SP-C 的联合作用调节磷脂膜的通透性和动态性。
Biochem J. 2011 Sep 15;438(3):555-64. doi: 10.1042/BJ20110681.
8
Pulmonary surfactant protein SP-C counteracts the deleterious effects of cholesterol on the activity of surfactant films under physiologically relevant compression-expansion dynamics.肺表面活性物质蛋白 SP-C 可对抗胆固醇在生理相关压缩-扩张动力学下对表面活性剂膜活性的有害影响。
Biophys J. 2009 Nov 18;97(10):2736-45. doi: 10.1016/j.bpj.2009.08.045.
9
Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs.一种抗磷脂酶的合成表面活性剂在大鼠肺中的活性及抗抑制性
Am J Respir Cell Mol Biol. 2007 Oct;37(4):387-94. doi: 10.1165/rcmb.2006-0434OC. Epub 2007 Jun 7.
10
A small key unlocks a heavy door: The essential function of the small hydrophobic proteins SP-B and SP-C to trigger adsorption of pulmonary surfactant lamellar bodies.小钥匙开启重门:小疏水蛋白SP-B和SP-C触发肺表面活性物质板层小体吸附的基本功能
Biochim Biophys Acta. 2016 Aug;1863(8):2124-34. doi: 10.1016/j.bbamcr.2016.04.028. Epub 2016 May 4.

引用本文的文献

1
Surfactant protein SP-B: one ring to rule the molecular and biophysical mechanisms of the pulmonary surfactant system.表面活性蛋白SP-B:掌控肺表面活性物质系统分子与生物物理机制的关键一环。
Biophys Rev. 2025 Mar 18;17(2):653-666. doi: 10.1007/s12551-025-01285-y. eCollection 2025 Apr.
2
Bacterial expression, purification and folding of exceptionally hydrophobic and essential protein: Surfactant Protein-B (SP-B).异常疏水且必需的蛋白质——表面活性蛋白B(SP-B)的细菌表达、纯化及折叠
PLoS One. 2025 Apr 25;20(4):e0321446. doi: 10.1371/journal.pone.0321446. eCollection 2025.
3
Cutting-edge perspectives on biosurfactants: implications for antimicrobial and biomedical applications.生物表面活性剂的前沿观点:对抗菌和生物医学应用的影响。
3 Biotech. 2024 Dec;14(12):297. doi: 10.1007/s13205-024-04146-9. Epub 2024 Nov 11.
4
Particles in Exhaled Air (PExA): Clinical Uses and Future Implications.呼出空气中的颗粒(PExA):临床应用及未来意义
Diagnostics (Basel). 2024 May 7;14(10):972. doi: 10.3390/diagnostics14100972.
5
The biophysical function of pulmonary surfactant.肺表面活性物质的生物物理功能。
Biophys J. 2024 Jun 18;123(12):1519-1530. doi: 10.1016/j.bpj.2024.04.021. Epub 2024 Apr 25.
6
Exposure to Aldehyde Cherry e-Liquid Flavoring and Its Vaping Byproduct Disrupt Pulmonary Surfactant Biophysical Function.接触醛樱桃电子液体调味剂及其蒸气的副产物会破坏肺表面活性剂的生物物理功能。
Environ Sci Technol. 2024 Jan 23;58(3):1495-1508. doi: 10.1021/acs.est.3c07874. Epub 2024 Jan 8.
7
Towards personalized therapies for genetic disorders of surfactant dysfunction.面向表面活性剂功能障碍遗传疾病的个体化治疗。
Semin Fetal Neonatal Med. 2023 Dec;28(6):101500. doi: 10.1016/j.siny.2023.101500. Epub 2023 Nov 22.
8
Molecular Impact of Conventional and Electronic Cigarettes on Pulmonary Surfactant.常规和电子烟对肺表面活性剂的分子影响。
Int J Mol Sci. 2023 Jul 20;24(14):11702. doi: 10.3390/ijms241411702.
9
Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk.表面活性剂蛋白候选途径分析鉴定出 CTSH 和 SFTA2,它们影响肺癌风险。
Hum Mol Genet. 2023 Sep 5;32(18):2842-2855. doi: 10.1093/hmg/ddad095.
10
Role of PPARγ in dyslipidemia and altered pulmonary functioning in mice following ozone exposure.PPARγ 在臭氧暴露后小鼠血脂异常和肺功能改变中的作用。
Toxicol Sci. 2023 Jun 28;194(1):109-119. doi: 10.1093/toxsci/kfad048.

本文引用的文献

1
Pulmonary surfactant protein SP-C counteracts the deleterious effects of cholesterol on the activity of surfactant films under physiologically relevant compression-expansion dynamics.肺表面活性物质蛋白 SP-C 可对抗胆固醇在生理相关压缩-扩张动力学下对表面活性剂膜活性的有害影响。
Biophys J. 2009 Nov 18;97(10):2736-45. doi: 10.1016/j.bpj.2009.08.045.
2
Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions.肺表面活性物质膜和薄膜的结构:蛋白质及脂蛋白相互作用的作用
Biochim Biophys Acta. 2008 Jul-Aug;1778(7-8):1676-95. doi: 10.1016/j.bbamem.2008.05.003. Epub 2008 May 11.
3
Surfactant proteins B and C are both necessary for alveolar stability at end expiration in premature rabbits with respiratory distress syndrome.表面活性蛋白B和C对于患有呼吸窘迫综合征的早产兔呼气末期的肺泡稳定性均是必需的。
J Appl Physiol (1985). 2008 Apr;104(4):1101-8. doi: 10.1152/japplphysiol.00865.2007. Epub 2008 Feb 14.
4
Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat Respiratory Distress Syndrome: role of the different components in an efficient pulmonary surfactant.用于治疗呼吸窘迫综合征的外源性天然表面活性剂制剂之间的生化和药理学差异:不同成分在有效肺表面活性剂中的作用
Eur J Pharmacol. 2007 Jul 30;568(1-3):1-15. doi: 10.1016/j.ejphar.2007.04.035. Epub 2007 Apr 30.
5
Effect of humidity on the stability of lung surfactant films adsorbed at air-water interfaces.湿度对吸附于空气-水界面的肺表面活性物质膜稳定性的影响。
Biochim Biophys Acta. 2006 Oct;1758(10):1609-20. doi: 10.1016/j.bbamem.2006.07.004. Epub 2006 Jul 20.
6
Protein-lipid interactions and surface activity in the pulmonary surfactant system.肺表面活性物质系统中的蛋白质-脂质相互作用及表面活性
Chem Phys Lipids. 2006 Jun;141(1-2):105-18. doi: 10.1016/j.chemphyslip.2006.02.017. Epub 2006 Mar 20.
7
Pulmonary surfactant function is abolished by an elevated proportion of cholesterol.肺表面活性物质的功能会因胆固醇比例升高而丧失。
Biochim Biophys Acta. 2005 Oct 15;1737(1):27-35. doi: 10.1016/j.bbalip.2005.09.002. Epub 2005 Oct 10.
8
Interaction of the N-terminal segment of pulmonary surfactant protein SP-C with interfacial phospholipid films.肺表面活性物质蛋白SP-C的N端片段与界面磷脂膜的相互作用。
Biochim Biophys Acta. 2005 Jul 30;1713(2):118-28. doi: 10.1016/j.bbamem.2005.06.002.
9
Inactivation of pulmonary surfactant due to serum-inhibited adsorption and reversal by hydrophilic polymers: experimental.血清抑制吸附导致肺表面活性物质失活及亲水性聚合物的逆转:实验研究
Biophys J. 2005 Sep;89(3):1769-79. doi: 10.1529/biophysj.105.062620. Epub 2005 May 27.
10
Pulmonary surfactant in allergic inflammation: new insights into the molecular mechanisms of surfactant function.过敏性炎症中的肺表面活性物质:对表面活性物质功能分子机制的新见解
Am J Physiol Lung Cell Mol Physiol. 2005 Apr;288(4):L608-9. doi: 10.1152/ajplung.00434.2004.

SP-B 和 SP-C 蛋白在肺表面活性物质膜表面行为和机械稳定性中的联合和独立作用。

Combined and independent action of proteins SP-B and SP-C in the surface behavior and mechanical stability of pulmonary surfactant films.

机构信息

Departamento de Bioquímica, Universidad Complutense, Madrid, Spain.

出版信息

Biophys J. 2010 Nov 17;99(10):3290-9. doi: 10.1016/j.bpj.2010.09.039.

DOI:10.1016/j.bpj.2010.09.039
PMID:21081077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2980747/
Abstract

The hydrophobic proteins SP-B and SP-C are essential for pulmonary surfactant function, even though they are a relatively minor component (<2% of surfactant dry mass). Despite countless studies, their specific differential action and their possible concerted role to optimize the surface properties of surfactant films have not been completely elucidated. Under conditions kept as physiologically relevant as possible, we tested the surface activity and mechanical stability of several surfactant films of varying protein composition in vitro using a captive bubble surfactometer and a novel (to our knowledge) stability test. We found that in the naturally derived surfactant lipid mixtures, surfactant protein SP-B promoted film formation and reextension to lower surface tensions than SP-C, and in particular played a vital role in sustaining film stability at the most compressed states, whereas SP-C produced no stabilization. Preparations containing both proteins together revealed a slight combined effect in enhancing film formation. These results provide a qualitative and quantitative framework for the development of future synthetic therapeutic surfactants, and illustrate the crucial need to include SP-B or an efficient SP-B analog for optimal function.

摘要

疏水蛋白 SP-B 和 SP-C 对肺表面活性物质的功能至关重要,尽管它们在表面活性物质中只占相对较小的比例(<2%)。尽管进行了无数的研究,但它们的具体差异作用及其可能协同优化表面活性物质膜表面性质的作用仍未完全阐明。在尽可能保持生理相关的条件下,我们使用俘获气泡表面张力仪和一种新颖的(据我们所知)稳定性测试,在体外测试了不同蛋白组成的几种表面活性物质膜的表面活性和机械稳定性。我们发现,在天然衍生的表面活性脂质混合物中,表面活性蛋白 SP-B 促进了膜的形成和再延伸,使表面张力降低到比 SP-C 更低的水平,特别是在最压缩状态下对维持膜的稳定性起着至关重要的作用,而 SP-C 则没有稳定作用。含有这两种蛋白的制剂显示出略微的协同作用,增强了膜的形成。这些结果为未来合成治疗性表面活性物质的发展提供了定性和定量的框架,并说明了包含 SP-B 或高效 SP-B 类似物以获得最佳功能的迫切需要。